Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
The effect of chronic (CCR) and intermittent (ICR) caloric restriction on serum insulin-like growth factor (IGF)-I levels and mammary tumor (MT) development was investigated. Ten-week-old MMTV-TGF-alpha female mice were assigned to ad libitum-fed (AL; AIN-93M diet), ICR [3-week 50% caloric restriction using AIN-93M-mod diet, 2x protein, fat, vitamins, and minerals followed by 3 weeks of daily 100% AL consumption of AIN-93M ( approximately 75% of AL for each 6-week cycle)], and CCR (calorie and nutrient intake matched for each 6-week ICR cycle) groups. Half of the mice from each group were sacrificed at 79 (end of restriction) or 82 (end of refeeding) weeks of age. Serum was obtained at euthanasia and in cycles 1, 3, 5, 8, and 11. MT incidence was 71.0%, 35.4%, and 9.1% for AL, CCR, and ICR mice. ICR-Restricted mice had significantly lower terminal serum IGF-I and IGF-I/IGF binding protein-3 (IGFBP-3) ratio than CCR, ICR-Refed, and AL mice. There were no differences in terminal IGFBP-3. Final body, internal, and mammary fat pad weights correlated positively with IGF-I and negatively with IGFBP-3. Few changes were found for protein expression of IGF-IRalpha and IGFBP-3 in mammary tissue and MTs. During the study, IGF-I levels of ICR-Restricted mice were reduced, whereas refeeding allowed partial recovery. For all groups, elevated IGF-I levels preceded MT detection, although not all values were significant versus mice without MTs. However, the specific role of IGF-I in the protective effect of calorie restriction remains to be determined. These results confirm that ICR prevents MT development to a greater extent than CCR.
Rogozina
Olga P
OP
The Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912, USA. mpcleary@hi.umn.edu
Bonorden
Melissa J L
MJ
Grande
Joseph P
JP
Cleary
Margot P
MP
D000273:Adipose Tissue / Q000473:pathology; D000818:Animals; D001835:Body Weight / Q000502:physiology; D031204:Caloric Restriction; D002277:Carcinoma / Q000097:blood / Q000178:diet therapy*; D004435:Eating / Q000502:physiology; D005260:Female; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008325:Mammary Neoplasms, Experimental / Q000097:blood / Q000178:diet therapy* / Q000473:pathology; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics; D051379:Mice; D008813:Mice, Inbred ICR; D008822:Mice, Transgenic; D010507:Periodicity; D013997:Time Factors; D016211:Transforming Growth Factor alpha / Q000235:genetics*; D019076:Transgenes / Q000235:genetics
D016211:Transforming Growth Factor alpha; D007334:Insulin-Like Growth Factor I